Drugs & medicalClass II

Mylan Pharmaceuticals Inc recalls Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505,…

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Read the official notice →
Date
2026-09-09
Country
United States
Brand
Mylan Pharmaceuticals
Product
Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made…
Classification
Class II
Units
Nationwide within the U.S
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Mylan Pharmaceuticals recalls

  1. 2026-09-09
  2. US
  3. 2026-08-26
  4. US
  5. 2026-08-05
  6. US
  7. 2026-03-11
  8. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan…

    Failed Dissolution Specifications

    FDA · DrugMYLAN PHARMACEUTICALS INCNationwide within the United StatesOfficial notice →
  9. 2025-03-26
  10. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…

    Failed Dissolution Specifications - low dissolution results

    FDA · DrugMYLAN PHARMACEUTICALS INCUS Nationwide.Official notice →
  11. 2022-08-03
  12. US
    Drugs & medicalClass I

    Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons…

    Labeling: Missing label: Label missing from some prefilled pens.

    FDA · DrugMylan Pharmaceuticals IncProduct was distributed nationwide within the United StatesOfficial notice →
All 12 Mylan Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2026-09-09
  2. US
    Drugs & medicalClass I

    Baxter Healthcare Corporation recalls 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation,…

    Presence of particulate matter: Particulates identified as fiberglass

    FDA · DrugBaxter Healthcare CorporationNatonwide in the USAOfficial notice →
  3. US
    Drugs & medicalClass II

    Golden State Medical Supply Inc. recalls Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC:…

    Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

    FDA · DrugGolden State Medical Supply Inc.US Nationwide.Official notice →
  4. US
  5. US
    Drugs & medicalClass III

    Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi…

    Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

    FDA · DrugChiesi USA, Inc.MO, TNOfficial notice →
  6. US
  7. US
See all drugs & medical recalls →